Zimmer Biomet Holdings, Inc.ZBHNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-26.1%
5Y CAGR-31.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-26.1%/yr
vs +40.5%/yr prior
5Y CAGR
-31.4%/yr
Recent acceleration
Acceleration
-66.6pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.50% |
| Q3 2025 | 2.29% |
| Q2 2025 | 2.44% |
| Q1 2025 | 1.94% |
| Q4 2024 | -2.78% |
| Q3 2024 | 2.01% |
| Q2 2024 | 1.39% |
| Q1 2024 | -4.77% |
| Q4 2023 | -3.08% |
| Q3 2023 | -1.02% |
| Q2 2023 | 6.97% |
| Q1 2023 | 2.22% |
| Q4 2022 | 6.19% |
| Q3 2022 | 2.31% |
| Q2 2022 | 2.58% |
| Q1 2022 | -14.55% |
| Q4 2021 | 20.90% |
| Q3 2021 | -43.15% |
| Q2 2021 | 103.70% |
| Q1 2021 | -19.00% |
| Q4 2020 | 16.41% |
| Q3 2020 | -2.05% |
| Q2 2020 | -10.87% |
| Q1 2020 | -18.74% |
| Q4 2019 | 5.86% |
| Q3 2019 | 2.05% |
| Q2 2019 | 10.23% |
| Q1 2019 | 0.49% |
| Q4 2018 | 5.75% |
| Q3 2018 | -3.43% |
| Q2 2018 | 3.55% |
| Q1 2018 | 0.74% |
| Q4 2017 | 4.17% |
| Q3 2017 | -1.51% |
| Q2 2017 | 1.65% |
| Q1 2017 | -4.81% |
| Q4 2016 | 0.10% |
| Q3 2016 | 7.90% |
| Q2 2016 | 3.38% |
| Q1 2016 | -0.23% |